Colorectal Cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects must meet all of the following criteria to be included in this retrospective study: A. Aged 18 to 75 years, male or female; B. histologically diagnosed adenocarcinoma of the colon or rectum; C. metastatic disease (not amenable to curative resection); D. RAS and BRAF wild-type; E. complete imaging assessment data: including baseline and PD data confirmed by CT or MRI; F. treated with the study's specified treatment regimen.
Exclusion criteria
Exclusion criteria: Subjects will not be included in this study if any of the following conditions are met: A. Other concomitant anti-tumor treatment; B. History of other malignant tumors except CRC within the past 5 years, except for cured cervical carcinoma in situ, basal skin cancer or squamous cell carcinoma; C. Participating in other clinical trials of anti-tumor drugs during the treatment period.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Progression Free Survival;Adverse Events;Failure-free survival; | — |
Secondary
| Measure | Time frame |
|---|---|
| Overall Survival;Objective response rate;Quality of Life;Compliance;Disease control rate; | — |
Countries
China
Contacts
Fujian Medical University Union Hospital